Endocrinology Information Center
Artificial intelligence software that can detect diabetic retinopathy has been approved by the U.S. Food and Drug Administration.
Benefits seen in markers of cardiometabolic disease, including insulin sensitivity
Increased adiposity in childhood may negatively impact liver function in children as young as 8 years old.
ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c level between 7% and 8% in most people with type 2 diabetes.
The utility and effectiveness of wearable fitness devices are discussed in a clinician's opinion piece.
Obesity is a chronic, progressive disease, and continued communication on prevention and treatment is paramount to reversing the status quo.
UTIs present clinically as dysuria, with symptoms of frequent and urgent urination secondary to irritation of the urethral and bladder mucosa.
A middle-aged patient with morbid obesesity and COPD complains about having shortness of breath at rest and dyspnea on exertion.
With the holiday season in full swing, clinicians and patients alike face difficulties in staying healthy and happy. Click through ...
Alpha-lipoic acid, 600mg daily, is an effective treatment option for patients with diabetic peripheral neuropathy.
Patients should be encouraged to incorporate daily exercise into their treatment regimen.
When symptoms of thyroid disease are present, clinicians should check thyroid antibodies even if thyroid function is normal.
SGLT2 receptor blockers are only approved for type 2 diabetes.
An older male patient started antidepressants for neuropathy pain but developed hyponatremia as a result.
An obese patient with chronic hepatitis C, diabetes, advanced cirrhosis, and fatty pancreas presents with chronic right-to-middle upper-abdomen pain.